Intellectual Property
2010
Mueller J.M., Facilitating Patient Access to Patent-Protected Genetic Testing, Journal of Business & Technology Law, Vol. 6, No. 1, 2010
2009
SIMON B.M., How To Get a Fair Share: IP Policies For Publicly Supported Biobanks, Stanford Journalof Law, Science and Policy, 2009
VAN OVERWALLE G. (ed.), Gene Patents and Collaborative Licensing Models. Patent Pools, Clearinghouses, Open Source Models and Liability Regimes, Cambridge, Cambridge University Press, 2009
2008
GOLD R., CARBONE J., Myriad Genetics: In the Eye of the Policy Storm, 2008, in rete, www.theinnovationpartnership.org
2007
HOLMAN C.M, The Impact of Human Gene Patents on Innovation and Access: A Survey of Human Gene Patent Litigation, 76 UMKC L. Rev. 295 (2007)
HOPKINS M.M., MAHDI S., PATEL P., THOMAS S.M., DNA Patenting: The End o fan Era?, 25 Nat. Biotech, 185 (2007)
2006
CAFORIO G., I trovati biotecnologici tra i principi etico-giuridici e il codice di proprietà industriale, Torino, 2006
CAULFIELD T., COOK-DEEGAN R.M., KIEFF F.S.,WALSH J.P., Evidence and Anectodes: an Analysis of Human Gene Patenting Controversies, 24 Nature Biotech, 1091 (2006)
GREENFIELD D.L., Greenberg v. Miami Children’s Hospital: Unjust Enrichment and the Patenting of Human Genetic Material, 15 Annals of Health Law, 213 (2006)
2005
EBERSOLE T.J., GUTHRIE M.C., GOLDSTEIN J.A., Patent Pool as a Solution to The Licensing Problems of Diagnostics Genetics, 17 Intellect. Prop. Technol. Law J., 6 (2005)
GOLD R., CAULFIELD T., JOLY J., Genetic Research Tool, The Research Exception and Open Science, 3 GenEdit, 1 (2005)
JENSEN K., MURRAY F., Intellectual Property. Enhanced: Intellectual Property Landscape of Human Genome, 310 Science, 239 (2005)
LIIVAK O., The Forgotten Originality Requirement: A Constitutional Hurdle for Gene Patents, 87 J. Pat. & Trademark Off. Soc’y, 261 (2005)
2004
MATTHIJS G., Patenting Genes May Slow Down Innovation, and Delay Availability of Cheaper Genetic Tests, 329 British Medical Journal, 1359 (2004)
2003
CHO M.K., Effects of Patents and Licenses on the Provision of Clinical Genetic Testing Service, 5 J. Molecular Diagnostics, 3 (2003)
CHO M., ILLANGASEKARE S., WEAVER M., LEONARD D., MERZ J., Effects of Patents and Licenses on the Provision of Clinical Genetic Testing Service, 5 J. Mol. Diagn., 3 (2003)
2002
ANDREWS L.B, Genes and Patent Policy: Rethinking Intellectual Property Rights, 3 Nat. Rev., 803 (2002)
ANDREWS L.B., The Gene Patent Dilemma: Balancing Commercial Incentives With Health Needs, 2 Houston Journal of Health Law & Policy, 65 (2002)
BARTON J.H., United States Law of Genomic and Post Genomic Patents, in 33 Intenational Review of Industrial Property and Copyright Law, 779 (2002)
GOLD R., CAULFIELD T., The Moral Toolboth: a Method that Makes Use of the Patent System to Address Ethical Concern in Biotechnology, 359 Lancet, 2268 (2002)
2001
BOBROW M., THOMAS S., Patents in a Genetic Age, 409 Nature, 763 (2001)
FAELLI T., La tutela delle invenzioni biotecnologiche in Europa: prime valutazioni di insieme, in Dir. ind., 2001, I, 129
2000
CAULFIELD T., GOLD R., CHO M.K., Patenting Human Genetic Material: Refocusing the Debate, 1 Nat. Rev., 227 (2000)
1999
CAMPIGLIO C., I brevetti biotecnologici nel diritto comunitario, in Dir. comm. internaz., 1999, IV, 849
DI CATALDO V., La brevettabilità delle biotecnologie. Novità, attività inventiva, industrialità, in Dir. ind., I, 1999, 177
GUIDETTI B., La Direttiva 98/44/CE sulle invenzioni biotecnologiche, in Contratto e Impresa, 1999, I, 482
1998
BAGGOT B., Patenting Transgenic in the European Union, 16(3) Nat. Biotechnol., 299 (1998)
BEGHÈ LORETI A., MARINI L., La protezione giuridica delle invenzioni biotecnologiche, in Diritto dell’Unione Europea, 4-1998, 793
HELLER M., EISENBERG R., Can Patents Deter Innovation? The Anticommons in Biomedical Research, 280 Science, 698 (1998)
1996
CAPLAN A.L., MERZ J.F., Patenting Gene Sequences, 312 British Med. J., 926 (1996)
1994
BEIER F.K. , MOUFANG R., Patentability of human genes and living organism, in Dir. ind., 1994, I, 340
GRUNWALD R., VOGEL F., Patenting of Human Genes and Living Organism, New York, 1994
1992
CASUCCI G.F., Onco-mouse Harvard: 3° atto. Il problema della liceità, in Dir. ind., 1992, II, 158
EISENBERG R.S., Genes, Patents, and Product Development, 257 Science, 903 (1992)
KILEY T.D., Patents on Random Complementary DNA Fragments?, 257 Science, 915 (1992)
KO Y., An Economic Analysis of Biotechnology Patent, 102 Yale L. Rev., 1992, 777
1991
DI CERBO V., “Il topo di Harvard” ovvero la manipolazione genetica di animali all’esame dell’Ufficio europeo dei brevetti, in Foro It., 1991, IV, 178
GREENFIELD M.S., Recombinant DNA Technology: A Science Struggling with the Patent Law, 44 Stanf. f. L. Rev., 1991, 1051
1985